Editorial: Bile Acid Profiles in Intrahepatic Cholestasis of Pregnancy: Is This the Solution to the Enigma of Intrahepatic Cholestasis of Pregnancy?

Sinakos, Emmanouil; Lindor, Keith D.
March 2010
American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p596
Academic Journal
Intrahepatic cholestasis of pregnancy (ICP) is a rare pregnancy-related liver disease characterized by pruritus, abnormal liver function tests, and an increased risk of fetal complications. An increase in the levels of bile acids is considered to be the diagnostic hallmark of the disease. Ursodeoxycholic acid (UDCA) is currently the most effective therapy. Tribe et al. (this issue) hypothesized that measuring the longitudinal profiles of individual bile acids would provide further insight into the mechanisms of disease. They used a novel chromatography method, which allowed the simultaneous measurement of 15 serum bile acids between 16 weeks of pregnancy and 4 weeks post-partum. ICP was associated with a predominant rise in cholic acid conjugated with taurine and glycine from 24 weeks of pregnancy. UDCA treatment significantly reduced serum taurocholic and taurodeoxycholic acid concentrations. Finally, bile acid profiles were similar in normal pregnancy and pregnancy associated with pruritus gravidarum. The study by Tribe et al. (this issue) presents a significant contribution to the solution of this enigmatic disease by expanding our knowledge on the pathophysiology of ICP and proposing a convenient method for diagnosis and monitoring of this disorder.


Related Articles

  • Longitudinal Profiles of 15 Serum Bile Acids in Patients With Intrahepatic Cholestasis of Pregnancy. Tribe, Rachel M.; Dann, Anthony T.; Kenyon, Anna P.; Seed, Paul; Shennan, Andrew H.; Mallet, Anthony // American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p585 

    OBJECTIVES:Increased maternal serum bile acids are implicated in intrahepatic cholestasis of pregnancy. Individual bile acid profiles and their relationship with disease progression, however, remain unknown. The purpose of this prospective study was to determine the temporal changes in bile...

  • Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid. Joutsiniemi, Titta; Timonen, Susanna; Linden, Maria; Suvitie, Pia; Ekblad, Ulla // BMC Gastroenterology;Jul2015, Vol. 15 Issue 1, p1 

    Background: To exam the biochemical, obstetric management and pregnancy outcome in women with intrahepatic cholestasis of pregnancy (ICP) and treatment with ursodeoxycholic acid (UDCA). Methods: Pregnancy outcome in patients with ICP (N = 307) was studied and patients treated with UDCA (N = 208)...

  • Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial. ZHANG, L.; LIU, X.-H.; QI, H.-B.; LI, Z.; FU, X.-D.; CHEN, L.; SHAO, Y. // European Review for Medical & Pharmacological Sciences;2015, Vol. 19 Issue 19, p3770 

    OBJECTIVE: Intrahepatic cholestasis of pregnancy (ICP) is a special complication of pregnancy characterized by skin pruritus, abnormal liver function tests and bile acids. To compare the efficacy of ursodeoxycholic acid (UDCA) and S-adenosylmethionine (SAMe) monotherapy with their combined...

  • Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis. Gurung, Vinita; Williamson, Catherine; Chappell, Lucy; Chambers, Jenny; Briley, Annette; Pipkin, Fiona Broughton; Thornton, Jim // BMC Pregnancy & Childbirth;2009, Vol. 9, Special section p1 

    Background: Obstetric cholestasis (OC) is a serious problem in pregnancy. It affects about 4500 women per year in the UK. Affected women develop itching and occasionally jaundice. More importantly, the condition is associated with premature delivery, fetal distress and is believed to be an...

  • Ursodeoxycholic Acids: A Safe and Effective Agent for Dissolving Cholesterol Gallstones. Tint, G. Stephen; Salen, Gerald; Colalillo, Anthony; Graber, David; Verga, Diane; Speck, Jeffrey // Annals of Internal Medicine;Sep82, Vol. 97 Issue 3, p351 

    Presents a study which examined the effectiveness of using ursodeoxycholic acid in dissolving cholesterol gallstones and their effect on hepatic bile acid metabolism and liver function. Methods used in the study; Results.

  • Analysis of serum bile acids by isotope dilution-mass spectrometry to assess the performance of routine total bile acid methods. Ducroq, D. H.; Morton, M. S.; Shadi, N.; Fraser, H. L.; Strevens, C.; Morris, J.; Thomas, M. A. // Annals of Clinical Biochemistry;Nov2010, Vol. 47 Issue 6, p535 

    Background: WEQAS, one of the largest EQA (External Quality Assessment) providers in the UK, offers a bile acid EQA scheme, with linear serum pools containing cholic acid, deoxycholic acid and chenodeoxycholic acid, reflecting levels observed in obstructive cholestasis. Total bile acids are...

  • Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient. Katsinelos, Panagiotis; Kountouras, Jannis; Chatzimavroudis, Grigoris; Zavos, Christos; Pilpilidis, Ioannis; Paroutoglou, George; Llado, Laura // World Journal of Gastroenterology;9/7/2008, Vol. 14 Issue 33, p5223 

    A 76-year-old diabetic man underwent cholecystectomy for gangrenous calculous cholecystitis. His postoperative course was complicated by the development of Candida albicans esophagitis necessitating antifungal therapy, and total parenteral nutrition (TPN) for 15 d. Seven weeks after...

  • The Effect of Ursodeoxycholic Acid Therapy on Gallstone Formation in the Morbidly Obese during Rapid Weight Loss. Worobetz, L. J.; Inglis, F. G.; Shaffer, E. A. // American Journal of Gastroenterology;Oct1993, Vol. 88 Issue 10, p1705 

    Obesity is a significant risk factor for cholesterol gallstone formation, particularly when patients are morbidly obese and rapidly losing weight. Our objective, in a double-blind, placebo-driven trial of ursodeoxycholic acid, was to study the prevention of gallstone development in 29 morbidly...

  • Fetal Outcomes in Pregnancies Complicated by Intrahepatic Cholestasis of Pregnancy in a Northern California Cohort. Rook, Michelle; Vargas, Juan; Caughey, Aaron; Bacchetti, Peter; Rosenthal, Philip; Bull, Laura // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Intrahepatic cholestasis of pregnancy (ICP) has important fetal implications. There is increased risk for poor fetal outcomes, including preterm delivery, meconium staining of amniotic fluid, respiratory distress, fetal distress and demise. Methods: One hundred and one women...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics